Mountain Hill Investment Partners Corp. Biogen Inc. Transaction History
Mountain Hill Investment Partners Corp.
- $114 Billion
- Q3 2025
A detailed history of Mountain Hill Investment Partners Corp. transactions in Biogen Inc. stock. As of the latest transaction made, Mountain Hill Investment Partners Corp. holds 75 shares of BIIB stock, worth $12,566. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$12,566
Previous $9.42 Million
11.54%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,075Shares Held
131MCall Options Held
3.77MPut Options Held
2.31M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.9 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15MShares$2.51 Billion1.66% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.44 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.32MShares$1.23 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.25MShares$712 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $24.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...